188 related articles for article (PubMed ID: 17609820)
1. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast.
Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J
Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820
[TBL] [Abstract][Full Text] [Related]
2. Correlations in survivin expression with the expression of p53 and bcl-2 in invasive ductal carcinoma of the breast.
Al-Joudi FS; Iskandar ZA; Imran AK
Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):904-10. PubMed ID: 18041310
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression correlates with unfavourable prognoses in invasive ductal carcinoma of the breast.
Al-Joudi FS; Iskandar ZA; Imran AK
Med J Malaysia; 2007 Mar; 62(1):6-8. PubMed ID: 17682561
[TBL] [Abstract][Full Text] [Related]
4. BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.
Townsend PA; Dublin E; Hart IR; Kao RH; Hanby AM; Cutress RI; Poulsom R; Ryder K; Barnes DM; Packham G
J Pathol; 2002 May; 197(1):51-9. PubMed ID: 12081204
[TBL] [Abstract][Full Text] [Related]
5. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression predicts early recurrence in early-stage breast cancer.
Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations.
Cui LF; Guo XJ; Wei J; Liu FF; Fan Y; Lang RG; Gu F; Zhang XM; Fu L
Histopathology; 2008 Oct; 53(4):381-8. PubMed ID: 18764880
[TBL] [Abstract][Full Text] [Related]
8. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
Kleinberg L; Flørenes VA; Nesland JM; Davidson B
Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312
[TBL] [Abstract][Full Text] [Related]
9. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
10. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
11. The expression of p53 in invasive ductal carcinoma of the breast: a study in the North-East States of Malaysia.
Al-Joudi FS; Iskandar ZA; Rusli J
Med J Malaysia; 2008 Jun; 63(2):96-9. PubMed ID: 18942291
[TBL] [Abstract][Full Text] [Related]
12. S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation.
Arai K; Teratani T; Kuruto-Niwa R; Yamada T; Nozawa R
Eur J Cancer; 2004 May; 40(8):1179-87. PubMed ID: 15110881
[TBL] [Abstract][Full Text] [Related]
13. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
[TBL] [Abstract][Full Text] [Related]
14. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast.
Vasaturo F; Sallusti E; Gradilone A; Malacrino C; Nardo T; Avagnano G; Aglianò AM; Granato T; De Vincenzi B; Coppotelli G; Marzullo A; Soda G; Simonelli L; Modesti M; Scarpa S
Int J Oncol; 2005 Oct; 27(4):1005-11. PubMed ID: 16142317
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of metallothionein predicts chemoresistance in breast cancer.
Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
[TBL] [Abstract][Full Text] [Related]
16. Expression of the apoptosis inhibitor protein Survivin in primary laryngeal carcinoma and cervical lymph node metastasis.
Marioni G; Bertolin A; Giacomelli L; Marchese-Ragona R; Savastano M; Calgaro N; Marino F; De Filippis C; Staffieri A
Anticancer Res; 2006; 26(5B):3813-7. PubMed ID: 17094406
[TBL] [Abstract][Full Text] [Related]
17. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
[TBL] [Abstract][Full Text] [Related]
18. Expression of periostin in human breast cancer.
Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C
J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160
[TBL] [Abstract][Full Text] [Related]
19. Expression of survivin and clinical correlation in patients with breast cancer.
Sohn DM; Kim SY; Baek MJ; Lim CW; Lee MH; Cho MS; Kim TY
Biomed Pharmacother; 2006 Jul; 60(6):289-92. PubMed ID: 16876381
[TBL] [Abstract][Full Text] [Related]
20. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
